105 related articles for article (PubMed ID: 28087183)
1. Co-expression of tissue factor and IL-6 in immature endothelial cells of cerebral cavernous malformations.
Noshiro S; Mikami T; Kataoka-Sasaki Y; Sasaki M; Ohnishi H; Ohtaki S; Wanibuchi M; Mikuni N; Kocsis JD; Honmou O
J Clin Neurosci; 2017 Mar; 37():83-90. PubMed ID: 28087183
[TBL] [Abstract][Full Text] [Related]
2. Biological relevance of tissue factor and IL-6 in arteriovenous malformations.
Noshiro S; Mikami T; Kataoka-Sasaki Y; Sasaki M; Hashi K; Ohtaki S; Wanibuchi M; Mikuni N; Kocsis JD; Honmou O
Neurosurg Rev; 2017 Jul; 40(3):359-367. PubMed ID: 27542852
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of transmembrane endothelial junction proteins in human cerebral cavernous malformations.
Burkhardt JK; Schmidt D; Schoenauer R; Brokopp C; Agarkova I; Bozinov O; Bertalanffy H; Hoerstrup SP
Neurosurg Focus; 2010 Sep; 29(3):E3. PubMed ID: 20809761
[TBL] [Abstract][Full Text] [Related]
4. Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations.
Uranishi R; Awadallah NA; Ogunshola OO; Awad IA
Neurosurgery; 2002 Jan; 50(1):110-5; discussion 115-6. PubMed ID: 11844241
[TBL] [Abstract][Full Text] [Related]
5. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
6. In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.
Zhu Y; Wu Q; Fass M; Xu JF; You C; Müller O; Sandalcioglu IE; Zhang JM; Sure U
Neurosurgery; 2011 Sep; 69(3):722-31; discussion 731-2. PubMed ID: 21471841
[TBL] [Abstract][Full Text] [Related]
7. YKL-40 can promote angiogenesis in sporadic cerebral cavernous malformation (CCM).
Shi Y; Song Y; Liu P; Li P
J Clin Neurosci; 2019 Jun; 64():220-226. PubMed ID: 30948312
[TBL] [Abstract][Full Text] [Related]
8. Cerebral cavernous malformations with dynamic and progressive course: correlation study with vascular endothelial growth factor.
Jung KH; Chu K; Jeong SW; Park HK; Bae HJ; Yoon BW
Arch Neurol; 2003 Nov; 60(11):1613-8. PubMed ID: 14623736
[TBL] [Abstract][Full Text] [Related]
9. Safety of thrombolysis in patients with acute ischemic stroke and cerebral cavernous malformations.
Erdur H; Scheitz JF; Tütüncü S; Fiebach JB; Endres M; Werring DJ; Nolte CH
Stroke; 2014 Jun; 45(6):1846-8. PubMed ID: 24788970
[TBL] [Abstract][Full Text] [Related]
10. Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.
Girard R; Fam MD; Zeineddine HA; Tan H; Mikati AG; Shi C; Jesselson M; Shenkar R; Wu M; Cao Y; Hobson N; Larsson HBW; Christoforidis GA; Awad IA
J Neurosurg; 2017 Jul; 127(1):102-110. PubMed ID: 27494817
[TBL] [Abstract][Full Text] [Related]
11. Relevance of CCM gene polymorphisms for clinical management of sporadic cerebral cavernous malformations.
Rinaldi C; Bramanti P; Scimone C; Donato L; Alafaci C; D'Angelo R; Sidoti A
J Neurol Sci; 2017 Sep; 380():31-37. PubMed ID: 28870584
[TBL] [Abstract][Full Text] [Related]
12. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.
Ren AA; Snellings DA; Su YS; Hong CC; Castro M; Tang AT; Detter MR; Hobson N; Girard R; Romanos S; Lightle R; Moore T; Shenkar R; Benavides C; Beaman MM; Müller-Fielitz H; Chen M; Mericko P; Yang J; Sung DC; Lawton MT; Ruppert JM; Schwaninger M; Körbelin J; Potente M; Awad IA; Marchuk DA; Kahn ML
Nature; 2021 Jun; 594(7862):271-276. PubMed ID: 33910229
[TBL] [Abstract][Full Text] [Related]
13. Expression of integrins in cerebral arteriovenous and cavernous malformations.
Seker A; Yildirim O; Kurtkaya O; Sav A; Günel M; Pamir MN; Kiliç T
Neurosurgery; 2006 Jan; 58(1):159-68; discussion 159-68. PubMed ID: 16385340
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell disease: emerging knowledge from cerebral cavernous malformations.
Lampugnani MG; Malinverno M; Dejana E; Rudini N
Curr Opin Hematol; 2017 May; 24(3):256-264. PubMed ID: 28212190
[TBL] [Abstract][Full Text] [Related]
15. Congenital vascular malformations--cerebral lesions differ from extracranial lesions by their immune expression of the glucose transporter protein GLUT1.
Meijer-Jorna LB; Aronica E; van der Loos CM; Troost D; van der Wal AC
Clin Neuropathol; 2012; 31(3):135-41. PubMed ID: 22551917
[TBL] [Abstract][Full Text] [Related]
16. Genetic Screening of Pediatric Cavernous Malformations.
Merello E; Pavanello M; Consales A; Mascelli S; Raso A; Accogli A; Cama A; Valeria C; De Marco P
J Mol Neurosci; 2016 Oct; 60(2):232-8. PubMed ID: 27561926
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid binding protein 4 expression in cerebral vascular malformations: implications for vascular remodelling.
Cataltepe S; Arikan MC; Liang X; Smith TW; Cataltepe O
Neuropathol Appl Neurobiol; 2015 Aug; 41(5):646-56. PubMed ID: 24865546
[TBL] [Abstract][Full Text] [Related]
18. Cerebral cavernous malformations: from genes to proteins to disease.
Cavalcanti DD; Kalani MY; Martirosyan NL; Eales J; Spetzler RF; Preul MC
J Neurosurg; 2012 Jan; 116(1):122-32. PubMed ID: 21962164
[TBL] [Abstract][Full Text] [Related]
19. CCM2 gene polymorphisms in Italian sporadic patients with cerebral cavernous malformation: a case-control study.
D'Angelo R; Scimone C; Rinaldi C; Trimarchi G; Italiano D; Bramanti P; Amato A; Sidoti A
Int J Mol Med; 2012 Jun; 29(6):1113-20. PubMed ID: 22378217
[TBL] [Abstract][Full Text] [Related]
20. Involvement of PTEN promoter methylation in cerebral cavernous malformations.
Zhu Y; Wloch A; Wu Q; Peters C; Pagenstecher A; Bertalanffy H; Sure U
Stroke; 2009 Mar; 40(3):820-6. PubMed ID: 19118244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
